Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
34.58
-0.13 (-0.37%)
At close: Jun 30, 2026, 4:00 PM EDT
34.58
0.00 (0.00%)
After-hours: Jun 30, 2026, 4:11 PM EDT
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $2.4 billion as of June 30, 2026. Its market cap has increased by 164.23% in one year.
Market Cap
2.40B
Enterprise Value
2.18B
1-Year Change
164.23%
Ranking
Category
Stock Price
$34.58
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $2.40B, an increase of 277.60%. That is a compound annual growth rate of 27.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 2.40B | 33.39% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 2.49B |
| Biohaven | 2.38B |
| Nurix Therapeutics | 2.37B |
| Vericel | 2.36B |
| Mineralys Therapeutics | 2.35B |
| Intellia Therapeutics | 2.33B |
| SELLAS Life Sciences Group | 2.30B |
| Immunome | 2.26B |